Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature

Since their license in 2008, studies on thrombopoietin receptor agonists (TPO-RAs) are proceeding at a fast pace. Their favorable efficacy and safety profile makes them good candidates for the management of thrombocytopenia in different settings, even beyond their current indications. In the last 10...

Descripción completa

Detalles Bibliográficos
Autores principales: Capecchi, Marco, Serpenti, Fabio, Giannotta, Juri, Pettine, Loredana, Reda, Gianluigi, Martinelli, Ida, Artoni, Andrea, Barcellini, Wilma, Fattizzo, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505995/
https://www.ncbi.nlm.nih.gov/pubmed/34650908
http://dx.doi.org/10.3389/fonc.2021.680411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505995/
https://www.ncbi.nlm.nih.gov/pubmed/34650908
http://dx.doi.org/10.3389/fonc.2021.680411

Ejemplares similares